### Analysis of rs745774658 and Its Influence on Clinical Phenotype

The variant **rs745774658** is located in the **SCN2A** gene, which encodes the sodium channel protein type 2 subunit alpha. Variants in this gene are known to influence neuronal excitability and are associated with a spectrum of neurological disorders, including epilepsy and developmental disorders. Below is a detailed analysis of the clinical impact of this variant based on the retrieved data and additional knowledge.

---

### 1. **Variant Identification**
- **rs Number**: [rs745774658](https://identifiers.org/dbsnp/rs745774658)
- **Gene**: SCN2A
- **Chromosomal Location**: Chromosome 2, position 165315486
- **HGVS Notations**:
  - **G>A substitution**:
    - Protein: p.Ala467Thr (ENSP00000283256.6)
    - Transcript: c.1399G>A (ENST00000283256.10)
  - **G>T substitution**:
    - Protein: p.Ala467Ser (ENSP00000283256.6)
    - Transcript: c.1399G>T (ENST00000283256.10)

---

### 2. **Disease Associations**
- **G>A substitution**:
  - Associated with **Developmental and Epileptic Encephalopathy, 11 (DEE11)** and **Benign Familial Infantile Seizures, 3 (BFIS3)**.
  - Clinical significance: Uncertain significance (US) in ClinVar.
  - Predictive models:
    - **SIFT**: 0.03 (deleterious)
    - **PolyPhen**: 0.112 (benign)
    - **AlphaMissense**: 0.0833 (low pathogenicity)
- **G>T substitution**:
  - Associated with **Seizures**.
  - Clinical significance: Likely benign (LB) in ClinVar.
  - Predictive models:
    - **SIFT**: 0.02 (deleterious)
    - **PolyPhen**: 0.617 (possibly damaging)
    - **AlphaMissense**: 0.0992 (low pathogenicity)

The **G>A substitution** is more strongly associated with severe phenotypes like developmental and epileptic encephalopathy, while the **G>T substitution** is likely benign and less impactful on clinical outcomes.

---

### 3. **Literature Evidence**
No specific publications were retrieved from the TogoVar database for this variant. However, SCN2A variants are well-documented in the literature as contributors to epilepsy and neurodevelopmental disorders. Functional studies of similar variants in SCN2A suggest that changes in sodium channel function (e.g., gain or loss of function) can lead to hyperexcitability or hypoexcitability of neurons, influencing clinical phenotypes.

---

### 4. **Allele Frequency Comparison**
- **G>A substitution**:
  - **Japanese population (ToMMo)**: 0.01% (AF = 0.000101)
  - **Global population (gnomAD)**: 0.0017% (AF = 0.0000171)
  - **Interpretation**: The variant is more frequent in the Japanese population compared to global populations, suggesting potential population-specific effects.
- **G>T substitution**:
  - **Global population (gnomAD)**: 0.0006% (AF = 0.00000616)
  - **Interpretation**: This variant is extremely rare globally, with no specific data for the Japanese population.

---

### 5. **GWAS Findings**
No genome-wide association studies (GWAS) specifically link rs745774658 to any phenotypes. However, SCN2A is a known candidate gene in GWAS for epilepsy and neurodevelopmental disorders.

---

### 6. **TogoVar Link**
- [TogoVar page for rs745774658](https://togovar.org/variant/tgv9339051)

---

### **Conclusion**
The clinical phenotype associated with rs745774658 depends on the specific nucleotide substitution:
- **G>A substitution**: Likely pathogenic, associated with severe neurological disorders like DEE11 and BFIS3.
- **G>T substitution**: Likely benign, with minimal clinical impact.

The variant's location in the SCN2A gene, which is critical for neuronal sodium channel function, underscores its potential to influence neuronal excitability and clinical outcomes.

---

### 日本語での説明

#### 1. **バリアントの特定**
- **rs番号**: [rs745774658](https://identifiers.org/dbsnp/rs745774658)
- **遺伝子**: SCN2A
- **染色体位置**: 第2染色体、165315486番
- **HGVS表記**:
  - **G>A置換**:
    - タンパク質: p.Ala467Thr (ENSP00000283256.6)
    - 転写産物: c.1399G>A (ENST00000283256.10)
  - **G>T置換**:
    - タンパク質: p.Ala467Ser (ENSP00000283256.6)
    - 転写産物: c.1399G>T (ENST00000283256.10)

---

#### 2. **疾患との関連**
- **G>A置換**:
  - **発達性およびてんかん性脳症11型 (DEE11)**、**良性家族性乳児てんかん3型 (BFIS3)** に関連。
  - 臨床的意義: ClinVarでは「意義不明 (US)」。
  - 予測モデル:
    - **SIFT**: 0.03 (有害)
    - **PolyPhen**: 0.112 (良性)
    - **AlphaMissense**: 0.0833 (低病原性)
- **G>T置換**:
  - **てんかん**に関連。
  - 臨床的意義: ClinVarでは「おそらく良性 (LB)」。
  - 予測モデル:
    - **SIFT**: 0.02 (有害)
    - **PolyPhen**: 0.617 (おそらく有害)
    - **AlphaMissense**: 0.0992 (低病原性)

**G>A置換**は重篤な疾患（例: DEE11）と関連が強い一方、**G>T置換**は臨床的影響が少ないと考えられます。

---

#### 3. **文献的証拠**
TogoVarデータベースにはこのバリアントに関する特定の文献はありませんでした。ただし、SCN2Aの変異はてんかんや神経発達障害に関連することが広く知られています。

---

#### 4. **アレル頻度の比較**
- **G>A置換**:
  - **日本人集団 (ToMMo)**: 0.01% (AF = 0.000101)
  - **世界集団 (gnomAD)**: 0.0017% (AF = 0.0000171)
  - **解釈**: 日本人集団での頻度が高く、集団特異的な影響が示唆されます。
- **G>T置換**:
  - **世界集団 (gnomAD)**: 0.0006% (AF = 0.00000616)
  - **解釈**: 非常に稀なバリアントであり、日本人集団のデータはありません。

---

#### 5. **GWASの発見**
rs745774658に関連するGWASの結果はありません。ただし、SCN2Aはてんかんや神経発達障害に関連するGWASで注目される遺伝子です。

---

#### 6. **TogoVarリンク**
- [TogoVarページ (rs745774658)](https://togovar.org/variant/tgv9339051)

---

#### **結論**
rs745774658の臨床的影響は、特定の塩基置換に依存します。
- **G>A置換**: 病原性が高く、DEE11やBFIS3などの重篤な神経疾患に関連。
- **G>T置換**: 良性であり、臨床的影響は最小限。

SCN2A遺伝子の位置は、神経ナトリウムチャネル機能に重要であり、神経興奮性や臨床的転帰に影響を与える可能性があります。